CIBC Asset Management’s Moderna MRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.33M | Sell |
48,158
-4,180
| -8% | -$115K | ﹤0.01% | 627 |
|
2025
Q1 | $1.48M | Sell |
52,338
-566
| -1% | -$16K | ﹤0.01% | 622 |
|
2024
Q4 | $2.2M | Sell |
52,904
-60,918
| -54% | -$2.53M | 0.01% | 563 |
|
2024
Q3 | $7.61M | Buy |
113,822
+6,794
| +6% | +$454K | 0.02% | 330 |
|
2024
Q2 | $12.7M | Buy |
107,028
+1,257
| +1% | +$149K | 0.05% | 222 |
|
2024
Q1 | $11.3M | Buy |
105,771
+6,039
| +6% | +$644K | 0.04% | 251 |
|
2023
Q4 | $9.92M | Buy |
99,732
+626
| +0.6% | +$62.3K | 0.04% | 257 |
|
2023
Q3 | $10.2M | Buy |
99,106
+9,493
| +11% | +$981K | 0.04% | 230 |
|
2023
Q2 | $10.9M | Sell |
89,613
-545
| -0.6% | -$66.2K | 0.04% | 222 |
|
2023
Q1 | $13.8M | Sell |
90,158
-1,007
| -1% | -$155K | 0.05% | 193 |
|
2022
Q4 | $16.4M | Sell |
91,165
-2,121
| -2% | -$381K | 0.07% | 173 |
|
2022
Q3 | $11M | Buy |
93,286
+2,753
| +3% | +$326K | 0.05% | 207 |
|
2022
Q2 | $12.9M | Buy |
90,533
+494
| +0.5% | +$70.6K | 0.05% | 187 |
|
2022
Q1 | $15.5M | Sell |
90,039
-568
| -0.6% | -$97.8K | 0.05% | 183 |
|
2021
Q4 | $23M | Buy |
90,607
+7,651
| +9% | +$1.94M | 0.08% | 144 |
|
2021
Q3 | $31.9M | Buy |
82,956
+30,443
| +58% | +$11.7M | 0.13% | 115 |
|
2021
Q2 | $12.3M | Buy |
52,513
+1,990
| +4% | +$468K | 0.05% | 202 |
|
2021
Q1 | $6.62M | Buy |
50,523
+7,222
| +17% | +$946K | 0.03% | 291 |
|
2020
Q4 | $4.52M | Buy |
43,301
+4,215
| +11% | +$440K | 0.02% | 327 |
|
2020
Q3 | $2.77M | Buy |
39,086
+26,903
| +221% | +$1.9M | 0.01% | 365 |
|
2020
Q2 | $782K | Hold |
12,183
| – | – | ﹤0.01% | 605 |
|
2020
Q1 | $365K | Hold |
12,183
| – | – | ﹤0.01% | 689 |
|
2019
Q4 | $238K | Buy |
+12,183
| New | +$238K | ﹤0.01% | 978 |
|